来自蛇毒的肌肉毒性脂酶A2类毒素的抑制剂和激活剂 - 结构概述
Guilherme H M Salvador1, Fábio F Cardoso1, Bruno Lomonte2
1Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu-SP, Brazil.
Biochimie
|August 1, 2024
概括
毒蛇咬伤会通过类似脂酶A2的毒素引起严重的组织损伤. 这篇评论探讨了抑制这些毒素的小分子,为补充抗毒素提供了潜在的新疗法.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒蛇咬伤对全球健康和经济造成重大负担,特别是在热带地区.
- 局部亡是一种严重的并发症,通常是由肌肉毒素引起的,包括脂酶A2类 (PLA2类) 毒素,这种毒素存在于Viperidae毒素中.
- 目前抗毒药在预防迅速组织损伤方面的局限性需要探索替代治疗策略.
研究的目的:
- 审查抑制PLA2类毒素的分子的结构相互作用.
- 讨论对PLA2类毒素肌毒性机制及其激活剂/抑制剂的影响.
- 根据结构和亲和力数据,提出PLA2类毒素抑制剂的分类.
主要方法:
- 文献综述侧重于PLA2类毒素及其抑制剂的结构生物学和生物化学研究.
- 分子相互作用和结构活动关系的分析.
- 对不同类别和子类别的抑制剂进行比较评估.
主要成果:
- 对表现出对类似PLA2的毒素有抑制作用的分子的概述.
- 确定PLA2类毒素激活剂和抑制剂之间的关键差异.
- 基于结构和亲缘关系数据,将抑制剂分为三类和五个子类.
结论:
- 小分子抑制剂提供了一种有希望的途径,用于管理蛇毒害造成的局部组织损伤.
- 了解抑制的结构基础对于开发有效的治疗剂至关重要.
- 这些发现可以指导新型抑制剂的开发,以增强当前的抗毒疗法.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
549
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
549
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Anticholinesterase Agents: Poisoning and Treatment
821
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
821
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
664
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
664
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
Opioid Receptors: Overview
650
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
650


